0000905148-24-001114.txt : 20240405
0000905148-24-001114.hdr.sgml : 20240405
20240405174857
ACCESSION NUMBER: 0000905148-24-001114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240403
FILED AS OF DATE: 20240405
DATE AS OF CHANGE: 20240405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smiley Joshua L
CENTRAL INDEX KEY: 0001725189
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38205
FILM NUMBER: 24827662
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zai Lab Ltd
CENTRAL INDEX KEY: 0001704292
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
BUSINESS PHONE: 862161632588
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
4
1
form4.xml
X0508
4
2024-04-03
0001704292
Zai Lab Ltd
ZLAB
0001725189
Smiley Joshua L
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100
CAMBRIDGE
MA
02142
true
See Remarks
false
American Depositary Shares
2024-04-03
4
M
0
7145
15.9
A
30672
D
American Depositary Shares
2024-04-04
4
S
0
1988
15.673
D
28684
D
Restricted Share Units
2024-04-03
4
M
0
7145
0
D
American Depositary Shares
7145
21435
D
Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
ADSs acquired upon vesting of Restricted Share Units ("RSUs").
These ADSs were sold automatically to cover taxes upon vesting of RSUs.
Each RSU represents a contingent right to receive one ADS.
The RSUs vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
President and Chief Operating Officer
/s/ Bruce Blefeld, Attorney-in-Fact
2024-04-05